{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:49:37Z","timestamp":1790732977519,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,16]],"date-time":"2014-08-16T00:00:00Z","timestamp":1408147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ijid.2014.06.020","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T09:16:46Z","timestamp":1410254206000},"page":"95-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus"],"prefix":"10.1016","volume":"28","author":[{"given":"Pingzheng","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Teter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-en","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2014.06.020_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jama.1995.03530020061033","article-title":"Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)","volume":"274","author":"Antonucci","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2014.06.020_bib0010","unstructured":"World Health Organization. Global tuberculosis report 2013. Geneva: WHO; 2013. Available at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/91355\/1\/9789241564656_eng.pdf (accessed December 23, 2013)."},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2014.06.020_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/00333549091240S206","article-title":"Integration of surveillance for STDs, HIV, hepatitis and TB: a survey of U.S.STD control programs","volume":"124","author":"Dowell","year":"2009","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ijid.2014.06.020_bib0020","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1086\/512679","article-title":"Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis","volume":"195","author":"Soriano","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2014.06.020_bib0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/QAI.0b013e31816de23c","article-title":"Interaction of hepatitis B and C viruses in patients infected with HIV","volume":"48","author":"Rong-Rong","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2014.06.020_bib0030","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2014.06.020_bib0035","unstructured":"World Health Organization. WHO policy on collaborative TB\/HIV activities: guidelines for national programmes and other stakeholders. Geneva: WHO; 2012. Available at: http:\/\/whqlibdoc.who.int\/publications\/2012\/9789241503006_eng.pdf (accessed May 12, 2012)."},{"key":"10.1016\/j.ijid.2014.06.020_bib0040","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2014.06.020_bib0045","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China\u2014declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2014.06.020_bib0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2014.06.020_bib0055","first-page":"1499","article-title":"The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity","volume":"8","author":"Fernandez-Villar","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2014.06.020_bib0060","first-page":"1027","article-title":"Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St. Petersburg, Russia","volume":"9","author":"Fry","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2014.06.020_bib0065","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1590\/S0102-311X2012000400009","article-title":"Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis","volume":"28","author":"Lima","year":"2012","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.ijid.2014.06.020_bib0070","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-3156.2007.01871.x","article-title":"Short communication: antituberculosis drug-induced hepatotoxicity is unexpectedly low in HIV-infected pulmonary tuberculosis patients in Malawi","volume":"12","author":"Tostmann","year":"2007","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijid.2014.06.020_bib0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2458-8-245","article-title":"Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand","volume":"8","author":"Sirinak","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijid.2014.06.020_bib0080","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/S1413-86702004000300004","article-title":"Efficacy and safety of efavirenz in HIV patients on rifampin for tuberculosis","volume":"8","author":"Pedral-Sampaio","year":"2004","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijid.2014.06.020_bib0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00408-013-9535-8","article-title":"Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis","volume":"192","author":"Liu","year":"2014","journal-title":"Lung"},{"key":"10.1016\/j.ijid.2014.06.020_bib0090","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1378\/chest.127.4.1304","article-title":"Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2014.06.020_bib0095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1378\/chest.06-2042","article-title":"Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy","volume":"131","author":"Kwon","year":"2007","journal-title":"Chest"},{"issue":"6 Pt 1","key":"10.1016\/j.ijid.2014.06.020_bib0100","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1164\/ajrccm.157.6.9711039","article-title":"Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus","volume":"157","author":"Ungo","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2014.06.020_bib0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QAI.0b013e3182a60f7d","article-title":"HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes","volume":"64","author":"Hamers","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2014.06.020_bib0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2893.2006.00797.x","article-title":"Treatment of hepatitis B with lamivudine and tenofovir in HIV\/HBV-coinfected patients: factors associated with response","volume":"14","author":"Jain","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijid.2014.06.020_bib0115","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/PHH.0b013e3182a95607","article-title":"tuberculosis, viral hepatitis, and sexually transmitted diseases surveillance data, 2000-2010: identification of infectious disease syndemics in New York City","volume":"20","author":"Drobnik","year":"2014","journal-title":"J Public Health Manag Pract"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214015823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214015823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T13:22:16Z","timestamp":1650115336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971214015823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":23,"alternative-id":["S1201971214015823"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2014.06.020","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2014.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}